Ticker
ABSI

Price
5.64
Stock movement down
-0.10 (-1.74%)
Company name
Absci Corp
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Biotechnology
Market cap
521.11M
Ent value
460.23M
Price/Sales
154.40
Price/Book
1.78
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-
1 year return
237.72%
3 year return
-
5 year return
-
10 year return
-
Last updated: 2024-04-08

iO Charts is a Seeking Alpha partner

DIVIDENDS

ABSI does not pay dividends or no data was received

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales154.40
Price to Book1.78
EV to Sales136.36

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

FINANCIALS

Per share

Loading...
Per share data
Current share count92.39M
EPS (TTM)-1.21
FCF per share (TTM)-1.14

Income statement

Loading...
Income statement data
Revenue (TTM)3.38M
Gross profit (TTM)-3.28M
Operating income (TTM)-111.91M
Net income (TTM)-110.60M
EPS (TTM)-1.21
EPS (1y forward)-1.06

Margins

Loading...
Margins data
Gross margin (TTM)-97.16%
Operating margin (TTM)-3315.94%
Profit margin (TTM)-3277.01%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash107.32M
Net receivables210.00K
Total current assets201.38M
Goodwill21.34M
Intangible assets52.47M
Property, plant and equipment0.00
Total assets339.39M
Accounts payable1.86M
Short/Current long term debt22.14M
Total current liabilities30.03M
Total liabilities46.45M
Shareholder's equity292.94M
Net tangible assets240.48M

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-79.85M
Capital expenditures (TTM)23.93M
Free cash flow (TTM)-103.78M
Dividends paid (TTM)0.00

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-37.75%
Return on Assets-32.59%
Return on Invested Capital-36.15%
Cash Return on Invested Capital-33.92%

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open5.72
Daily high5.76
Daily low5.49
Daily Volume1.02M
All-time high30.29
1y analyst estimate12.00
Beta-
EPS (TTM)-1.21
Dividend per share-
Ex-div date-
Next earnings date13 May 2024

Downside potential

Loading...
Downside potential data
ABSIS&P500
Current price drop from All-time high-81.38%-0.85%
Highest price drop-96.20%-56.47%
Date of highest drop26 Oct 20239 Mar 2009
Avg drop from high-82.08%-11.35%
Avg time to new high114 days13 days
Max time to new high674 days1805 days

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

COMPANY DETAILS
ABSI (Absci Corp) company logo
Marketcap
521.11M
Marketcap category
Small-cap
Description
Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process. Absci Corporation was founded in 2011 and is headquartered in Vancouver, Washington.
Employees
211
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...